Biosynex (ALBIO) — Cash Flow Reinvestment Rate
Latest as of December 2024:
2.19x
Biosynex (ALBIO) has a Cash Flow Reinvestment Rate of 2.19x as of December 2024, reinvesting €2.77 Million (capex €2.77 Million ) from operating cash flow of €1.26 Million. See Biosynex (ALBIO) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
2.19x
(Capex + Investments) / Operating CF
Total Reinvested
€2.77 Million
Capex + Investments
Operating Cash Flow
€1.26 Million
EUR
Capital Expenditures
€2.77 Million
EUR
Biosynex Cash Flow Reinvestment Rate (2009–2022)
Historical reinvestment intensity for Biosynex across 9 annual periods. For the full cash flow conversion analysis, see ALBIO cash flow conversion.
Annual Cash Flow Reinvestment Rate for Biosynex (2009–2022)
Year-by-year capital reinvestment analysis for Biosynex. See Biosynex financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 13.98x | €69.16 Million | €4.95 Million | €30.08 Million | ▲ +3101.6% |
| 2021 | 0.44x | €47.98 Million | €109.83 Million | €19.02 Million | ▼ -18.9% |
| 2020 | 0.54x | €17.04 Million | €31.64 Million | €9.12 Million | ▼ -93.5% |
| 2019 | 8.26x | €9.12 Million | €1.10 Million | €9.12 Million | ▼ -57.7% |
| 2018 | 19.52x | €9.12 Million | €467.12K | €9.12 Million | ▲ +3.8% |
| 2017 | 18.81x | €9.12 Million | €484.82K | €9.12 Million | — |
| 2016 | 0.00x | €0.00 | €489.91K | €0.00 | — |
| 2015 | 0.00x | €0.00 | €461.66K | €0.00 | ▼ -100.0% |
| 2009 | 0.65x | €46.92K | €72.40K | €46.92K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow